- API
Any substance that is represented for use in a drug and that, when used in the manufacturing, processing, or packaging ...
- Active Ingredient
Any component that is intended to furnish pharmacological activity or other direct effect in the diagnosis, cure, ...
- CAS No.
Unique number assigned to a specific chemical (identified by its chemical name) by the American Chemical Society and ...
Taxotere
Catalog No. | PI0139 |
---|---|
CAS No. | 114977-28-5 |
Molecular Formula | C43H53NO14 |
Molecular Weight | 807.88 |
Purity | 98% HPLC |
Package | 25 kg/drum |
Botanical Source | Taxaceae |
Appearance | White powder |
Storage | Stored in cool and dry places, protected from direct sunlight and heat. |
Shelf Life | 2 years |
Safety Tips of Taxotere
Handling of taxotere should only be performed by personnel trained and familiar with handling of potent active pharmaceutical ingredients. Moderate to severe irritant to the skin and eyes.
Related Applications
Circulatory System Care
The circulatory system is an organ system that passes nutrients, gases, hormones, blood cells, etc. to and from cells in the body to help fight diseases, stabilize body temperature and pH, and to maintain homeostasis. It's no secret that cardiovascular disease is the leading cause of death in all modern nations. Half of the population dies of heart attacks, strokes and other diseases related to the circulatory system. Many herbal extracts are beneficial to the circulatory system.
Related Researches
- 1. Anti-tumor efficacy of chitosan-g-poly(ethylene glycol) nanocapsules containing docetaxel: anti-TMEFF-2 functionalized nanocapsules vs. non-functionalized nanocapsules.
Torrecilla D, et al. Eur J Pharm Biopharm 2013 Apr;83(3):330-7.
- 2. Overall survival benefit for sequential doxorubicin-docetaxel compared with concurrent doxorubicin and docetaxel in node-positive breast cancer--8-year results of the Breast International Group 02-98 phase III trial.
Oakman C, et al. Ann Oncol 2013 May;24(5):1203-11.
- 3. Pluronic P105/F127 mixed micelles for the delivery of docetaxel against Taxol-resistant non-small cell lung cancer: optimization and in vitro, in vivo evaluation.
Chen L, et al. Int J Nanomedicine 2013;8:73-84.
- 4. The anti-cancer activity of a cationic anti-microbial peptide derived from monomers of polyhydroxyalkanoate.
O'Connor S, et al. Biomaterials 2013 Apr;34(11):2710-8.
- 5. Targeted co-delivery of docetaxel and siPlk1 by herceptin-conjugated vitamin E TPGS based immunomicelles.
Zhao J, et al. Biomaterials 2013 Apr;34(13):3411-21.
- 6. Targeted co-delivery of docetaxel, cisplatin and herceptin by vitamin E TPGS-cisplatin prodrug nanoparticles for multimodality treatment of cancer.
Mi Y, et al. J Control Release 2013 Feb 10.
- 7. A randomized phase II study of PEP02 (MM-398), irinotecan or docetaxel as a second-line therapy in patients with locally advanced or metastatic gastric or gastro-oesophageal junction adenocarcinoma.
Roy AC, et al. Ann Oncol 2013 Feb 13.
- 8. Visualization of Mitotic Arrest of Cell Cycle with Bioluminescence Imaging in Living Animals.
Zhang GJ, et al. Mol Imaging Biol 2013 Feb 26.
- 9. Chemotherapeutic drug delivery to cancer cells using a combination of folate targeting and tumor microenvironment-sensitive polypeptides.
Gao W, et al. Biomaterials 2013 May;34(16):4137-49.
- 10. Ulinastatin exerts synergistic effects with taxotere and inhibits invasion and metastasis of breast cancer by blocking angiogenesis and the epithelial-mesenchymal transition.
Gao F, et al. Cancer Biother Radiopharm 2013 Apr;28(3):218-25.